在帕金森病中错觉感染是二次的Piribedil升级:一个不常见的案例报告
Aziz Ahizoune1, Maha Ait Berri1
1Department of Neurology, Military Hospital Moulay Ismail of Meknès, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Cureus
|March 7, 2024
概括
妄想性感染 (DI) 可能发生在帕金森病 (PD) 患者中,有时与像piribedil.com这样的药物有关. 停止疑似药物是药物诱导的DI的推治疗方法.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 妄想性感染 (DI) 涉及到没有证据的感染的错误信念.
- 精神障碍可能是其他疾病的主要或次要的,包括精神疾病或物质使用.
- DI很少与帕金森病 (PD) 相关,通常与抗帕金森药物有关.
研究的目的:
- 在帕金森病 (PD) 患者中报告妄想感染 (DI) 的情况.
- 为了研究皮里贝迪尔 (piribedil) - - 一种多巴胺激素激动剂 - - 与DI的发展之间的潜在联系.
- 要突出药物诱导的PD中DI的管理策略.
主要方法:
- 一个81岁的男性PD患者的病例报告.
- 在皮里贝迪尔剂量升级后观察DI的发展.
- 关于与抗帕金森症药物相关的DI的文献综述.
主要成果:
- 患者在增加皮里贝迪尔剂量后出现了与妄想感染一致的症状.
- 这一案例表明,皮里贝迪尔与PD中的妄想感染之间存在潜在的关联.
- 没有发现感染信念的潜在医学或微生物学原因.
结论:
- 皮里贝迪尔可能会在易受帕金森病患者中加速或加剧妄想性感染.
- 对抗帕金森症药物的二次药物诱导的妄想感染需要仔细考虑.
- 取消涉及的药物是二次性DI的主要治疗方法.
相关概念视频
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
01:26Psychosis: Goals of Pharmacotherapy
128
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
128
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
137
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
137